Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $406.9700 (-1.89%) ($400.8400 - $415.1600) on Wed. Apr. 3, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.78% (three month average) | RSI | 50 | Latest Price | $406.9700(-1.89%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.2% a day on average for past five trading days. | Weekly Trend | REGN advances 0.3% a week on average for past two weeks. | Market Behavior | Value stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(59%) XLV(48%) IVW(40%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.89% in a week (0% probabilities). UUP(-11%) VXX(-10%) TLT(-6%) IFRA(-6%) TIP(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.89% (StdDev 1.78%) | Hourly BBV | 0 () | Intraday Trend | -1.8% | | | |
|
5 Day Moving Average | $409.49(-0.62%) | 10 Day Moving Average | $404.89(0.51%) | 20 Day Moving Average | $406.87(0.02%) | To recent high | -7.4% | To recent low | 9.4% | Market Cap | $43.15b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |